{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:00:30Z","timestamp":1760709630032,"version":"3.40.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Bioscience and Bioengineering"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jbiosc.2018.04.018","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T13:44:21Z","timestamp":1527601461000},"page":"522-526","source":"Crossref","is-referenced-by-count":6,"title":["Development of a novel immunoassay to select antibodies against intact membrane antigens by using the homogeneous AlphaLISA system"],"prefix":"10.1016","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6326-0983","authenticated-orcid":false,"given":"Satoshi","family":"Muneoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiaki","family":"Utsugisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Makino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbiosc.2018.04.018_bib1","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.biotechadv.2016.07.004","article-title":"Therapeutic monoclonal antibodies and derivatives: historical perspectives and future directions","volume":"34","author":"Rodgers","year":"2016","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jbiosc.2018.04.018_bib2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.7861\/clinmedicine.17-3-220","article-title":"Developments in therapy with monoclonal antibodies and related proteins","volume":"17","author":"Shepard","year":"2017","journal-title":"Clin. Med."},{"key":"10.1016\/j.jbiosc.2018.04.018_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cellsig.2017.09.005","article-title":"GPCRs: emerging anti-cancer drug targets","volume":"41","author":"Nieto Gutierrez","year":"2018","journal-title":"Cell. Signal."},{"key":"10.1016\/j.jbiosc.2018.04.018_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nrd.2017.91","article-title":"Opportunities for therapeutic antibodies directed at G-protein-coupled receptors","volume":"16","author":"Hutchings","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jbiosc.2018.04.018_bib5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd892","article-title":"The druggable genome","volume":"1","author":"Hopkins","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jbiosc.2018.04.018_bib6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/nbt1126","article-title":"Selecting and screening recombinant antibody libraries","volume":"23","author":"Hoogenboom","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jbiosc.2018.04.018_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/HAB-2009-0196","article-title":"Three decades of human monoclonal antibodies: past, present and future developments","volume":"18","author":"Steinitz","year":"2009","journal-title":"Hum. Antibodies"},{"key":"10.1016\/j.jbiosc.2018.04.018_bib8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1089\/adt.2009.9996","article-title":"AlphaLISA immunoassay platform- the \u201cno-wash\u201d high-throughput alternative to ELISA","volume":"7","author":"Bielefeld-Sevigny","year":"2009","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.jbiosc.2018.04.018_bib9","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/clinchem\/42.9.1518","article-title":"Luminescent oxygen channeling assay (LOCI): sensitive, broadly applicable homogeneous immunoassay method","volume":"42","author":"Ullman","year":"1996","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jbiosc.2018.04.018_bib10","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1523\/JNEUROSCI.09-03-01082.1989","article-title":"A\u00a0muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671","volume":"9","author":"Luther","year":"1989","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jbiosc.2018.04.018_bib11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/clinchem\/45.3.400","article-title":"TE671 cell-based ELISA for anti-acetylcholine receptor antibody determination in myasthenia gravis","volume":"45","author":"Franciotta","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jbiosc.2018.04.018_bib12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1309\/AJCPYEOR6SGE8ZLU","article-title":"Detection of acetylcholine receptor modulating antibodies by flow cytometry","volume":"143","author":"Lozier","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jbiosc.2018.04.018_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0304-3940(96)12488-5","article-title":"Stable functional expression of the adult subtype of human muscle acetylcholine receptor following transfection of the human rhabdomyosarcoma cell line TE671 with cDNA encoding the epsilon subunit","volume":"207","author":"Beeson","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jbiosc.2018.04.018_bib14","doi-asserted-by":"crossref","first-page":"e0185976","DOI":"10.1371\/journal.pone.0185976","article-title":"Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools","volume":"12","author":"Makino","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jbiosc.2018.04.018_bib15","doi-asserted-by":"crossref","first-page":"12613","DOI":"10.1074\/jbc.M108845200","article-title":"Yeast expression and NMR analysis of the extracellular domain of muscle nicotinic acetylcholine receptor alpha subunit","volume":"277","author":"Yao","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbiosc.2018.04.018_bib16","doi-asserted-by":"crossref","first-page":"26980","DOI":"10.1074\/jbc.M110731200","article-title":"Expression of soluble ligand- and antibody-binding extracellular domain of human muscle acetylcholine receptor alpha subunit in yeast Pichia pastoris. Role of glycosylation in alpha-bungarotoxin binding","volume":"277","author":"Psaridi-Linardaki","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbiosc.2018.04.018_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A\u00a0simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.jbiosc.2018.04.018_bib18","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/315592a0","article-title":"Production of human alpha-interferon in silkworm using a baculovirus vector","volume":"315","author":"Maeda","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.jbiosc.2018.04.018_bib19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1741-7007-10-80","article-title":"Rapid production of antigen-specific monoclonal antibodies from a variety of animals","volume":"10","author":"Kurosawa","year":"2012","journal-title":"BMC Biol."},{"key":"10.1016\/j.jbiosc.2018.04.018_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1472-6750-11-75","article-title":"Target-selective joint polymerase chain reaction: a robust and rapid method for high-throughput production of recombinant monoclonal antibodies from single cells","volume":"11","author":"Yoshioka","year":"2011","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.jbiosc.2018.04.018_bib21","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/mus.24057","article-title":"Targeting therapy to the neuromuscular junction: proof of concept","volume":"49","author":"Kusner","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jbiosc.2018.04.018_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1196\/annals.1405.007","article-title":"Myasthenia gravis and the tops and bottoms of AChRs: antigenic structure of the MIR and specific immunosuppression of EAMG using AChR cytoplasmic domains","volume":"1132","author":"Lindstrom","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jbiosc.2018.04.018_bib23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0896-6273(95)90037-3","article-title":"Three-dimensional location of the main immunogenic region of the acetylcholine receptor","volume":"15","author":"Beroukhim","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.jbiosc.2018.04.018_bib24","doi-asserted-by":"crossref","first-page":"13898","DOI":"10.1523\/JNEUROSCI.2833-09.2009","article-title":"Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity","volume":"29","author":"Luo","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jbiosc.2018.04.018_bib25","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.neuint.2010.01.011","article-title":"Different interaction between tricyclic antidepressants and mecamylamine with the human \u03b13\u03b24 nicotinic acetylcholine receptor ion channel","volume":"56","author":"Arias","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jbiosc.2018.04.018_bib26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuropharm.2017.06.011","article-title":"Nicotinic acetylcholine receptor inhibitors derived from snake and snail venoms","volume":"127","author":"Dutertre","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jbiosc.2018.04.018_bib27","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/jnnp.48.12.1246","article-title":"Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays","volume":"48","author":"Vincent","year":"1985","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jbiosc.2018.04.018_bib28","first-page":"1","article-title":"Myasthenia gravis","volume":"43","author":"Somnier","year":"1996","journal-title":"Dan. Med. Bull."},{"key":"10.1016\/j.jbiosc.2018.04.018_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/ajcp\/aqv009","article-title":"Detection of acetylcholine receptor blocking antibodies by flow cytometry","volume":"145","author":"Cromar","year":"2016","journal-title":"Am. J. Clin. Pathol."}],"container-title":["Journal of Bioscience and Bioengineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389172318300951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389172318300951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T19:46:39Z","timestamp":1604346399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389172318300951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1389172318300951"],"URL":"https:\/\/doi.org\/10.1016\/j.jbiosc.2018.04.018","relation":{},"ISSN":["1389-1723"],"issn-type":[{"type":"print","value":"1389-1723"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}